Related Experiment Video
Updated: Dec 1, 2025

Author Spotlight: Minimally Invasive Relief for Occipital Neuralgia at the Nuchal Line
Published on: September 13, 2024
Enhanced Recovery Protocol after Fronto-orbital Advancement Reduces Transfusions, Narcotic Usage, and Length of Stay
Rebecca Knackstedt1, Niyant Patel2
1Department of Plastic Surgery, Cleveland Clinic, Cleveland, Ohio.
Insights
Enhanced recovery after surgery (ERAS) protocols for fronto-orbital advancement (FOA) significantly reduced blood transfusions and narcotic use. This approach also decreased hospital length of stay, improving recovery for children with craniosynostosis.
Area of Science:
- Pediatric surgery
- Craniofacial surgery
- Enhanced recovery after surgery (ERAS) protocols
Background:
- Enhanced recovery after surgery (ERAS) protocols are multi-modal strategies to reduce patient morbidity, opioid consumption, and hospital stays.
- In 2013, modifications were implemented in the perioperative care for pediatric patients undergoing complex craniofacial procedures.
- This study aimed to evaluate the effectiveness of our ERAS protocol in children undergoing fronto-orbital advancement (FOA) for craniosynostosis.
Purpose of the Study:
- To analyze the outcomes of an ERAS protocol for pediatric patients undergoing fronto-orbital advancement (FOA).
- To assess the impact of the ERAS protocol on blood transfusion rates, narcotic utilization, and length of hospital stay.
- To determine the safety and efficacy of the multimodal ERAS approach in complex craniofacial surgery recovery.
Main Methods:
- A retrospective chart review was conducted for pediatric patients who underwent FOA for craniosynostosis between 2010 and 2018, post-IRB approval.
- The ERAS protocol, implemented in December 2013, included hemoglobin optimization, cell-saver technology, tranexamic acid, precise postoperative fluid management, and a defined transfusion algorithm.
- Analgesia focused on minimizing narcotics through scheduled acetaminophen, ibuprofen, or ketorolac, supplemented by dexmedetomidine, with opioids reserved for breakthrough pain.
Main Results:
- The ERAS group (55 patients) showed a significantly lower rate and volume of intraoperative transfusions compared to the control group (23 patients) (13/53 vs. 23/23, P < 0.0001; 183.4 mL vs. 339.8 mL, P = 0.05).
- Fewer ERAS patients required morphine/dilaudid (12/55 vs. 22/23, P < 0.0001), with reduced doses needed for those requiring it (2.8 vs. 11, P = 0.02).
- ERAS patients experienced a shorter hospital stay (2.3 vs. 3.6 nights, P < 0.0001) with no readmissions for common postoperative concerns.
Conclusions:
- The implemented ERAS protocol effectively reduced allogeneic blood transfusion rates, narcotic consumption, and hospital length of stay in pediatric FOA patients.
- The multimodal ERAS approach proved to be safe and effective for managing recovery after complex craniofacial surgery.
- This study supports the use of ERAS protocols in pediatric craniofacial surgery to optimize patient outcomes.
Background:
Enhanced recovery after surgery (ERAS) protocols utilize multi-modal approaches to decrease morbidity, narcotic usage, and length of stay. In 2013, we made several changes to our perioperative approach to children undergoing complex craniofacial procedures. The goal of this study was to analyze our protocol for children undergoing fronto-orbital advancement (FOA) for craniosynostosis.
Methods:
A retrospective chart review was performed after IRB approval, for children who underwent fronto-orbital advancement for craniosynostosis from 2010 to 2018. The ERAS protocol, initiated in December 2013, involves hemoglobin optimization, cell-saver technology, tranexamic acid, specific postoperative fluid titration, and a transfusion algorithm. The analgesic regimen focuses on narcotic reduction through the utilization of scheduled acetaminophen, ibuprofen, or ketorolac, and a dexmedetomidine infusion with opioids only for breakthrough pain.
Results:
Fifty-five ERAS protocol children and 23 control children were analyzed. ERAS children had a decreased rate (13/53 versus 23/23, P < 0.0001) and volume of intraoperative transfusion (183.4 mL versus 339.8 mL, P = 0.05). Fewer ERAS children required morphine/dilaudid (12/55 versus 22/23 P < 0.0001) and for children who required morphine, fewer doses were required (2.8 versus 11, P = 0.02). For ERAS protocol children who required PO narcotics, fewer doses were required (3.2 versus 5.3, P = 0.02). ERAS children had a decreased length of stay (2.3 versus 3.6 nights, P < 0.0001). No patients were re-admitted due to poor oral intake, pain, hemodynamic, or pulmonary concerns.
Conclusions:
Our ERAS protocol demonstrated a reduction in the overall and intraoperative allogenic blood transfusion rate, narcotic use, and hospital length of stay. This is a safe and effective multimodal approach to managing complex craniofacial surgical recovery.
Related Concept Videos
Suctioning the Nasopharyngeal Airway
Equipment Required
Parenteral Anesthetics: Overview
General Anesthesia: Overview
General anesthesia induces unconsciousness in the whole body, while the others target specific areas or sensations. It is administered to minimize adverse effects, maintain...
Endoscopic Procedures IV: Sigmoidoscopy and Laproscopy
Sigmoidoscopy
Sigmoidoscopy is a diagnostic procedure that uses a flexible sigmoidoscope equipped with a light source and camera to examine the rectum and sigmoid colon. The procedure involves inserting the tube through the anus...

